Timberland Bancorp director Robert A. Drugge sells 2,000 shares for $91,740

Reuters2026/08/18 19:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Director Robert A. Drugge exercised stock options for 2,000 Timberland Bancorp shares on Aug. 18, 2026 at $15.67.
He sold 2,000 shares the same day at $45.87.
Directly held common stock fell to 38,245 shares following the transactions.
Drugge also reported 12,100 stock options beneficially owned following the option exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Timberland Bancorp Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000939057-26-000197), on August 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Anthropic plans to grant supervoting rights to CEO Dario Amodei and other co-founders to ensure that the founding team can continue to lead the company after it goes public. As Amodei holds only about 2% of the shares, the supervoting rights are intended to strengthen his control. The company will also maintain a non-shareholder trustee structure, giving trustees the power to elect the majority of the board members.

华尔街见闻•2026/08/18 23:01

Hansen appoints TechnologyOne COO Stuart MacDonald as CEO effective Nov. 19

Reuters•2026/08/18 22:59

Hansen underlying EBITDA rises 31% to $119.6 million in FY26; revenue falls 1.5% to $386.5 million

Reuters•2026/08/18 22:58

Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares

Reuters•2026/08/18 22:57